生物系统工程有限公司（01355）于2026年11月3日发布截至2026年10月31日止月份的股份变动月报表，报告期内公司股本整体保持稳定。
公告显示，截至10月底，公司法定/注册股本仍为10,000,000,000股，每股面值0.01港元，法定/注册股本总额为1亿港元。已发行普通股数量自月初至月末均保持在1,789,597,740股，未出现新增发行、购回、注销或库藏股变动，公允反映公司股本在报告期内无增减变化。
公司于2031年到期的5,000万港元零息无抵押可换股债券仍维持原发行总额不变，转换价为每股0.129港元。本月期间没有因行使可换股债券而新增发行或转让库存股份的记录。
公司同时确认，当前已符合主板上市规则有关最低公众持股量的要求，并严格遵守相关法律法规规定。上述月报由公司秘书李柏聪签署。公司后续将继续依法履行信息披露义务。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.